Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Viridian Therapeutics
(1S1.F) Q4 2024
Earnings
1S1.F
Nov 12
Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.25
-1.08
-0.91
-0.73
Details
Expected EPS
-0.9958766375
Actual EPS
-1.0832424999999999
Surprise EPS
-0.09
Surprise Percent
-8.77%
Description
Viridian Therapeutics (1S1.F) has reported earnings of -1.0832424999999999 per share for Q4 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login